Work

Abstract LB002: Development of fully human anti-CD19 &CD22 bispecific tandem CAR-T for the treatment of resistant or relapsed B cell malignancies

Year: 2022
Type: conference-abstract
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: closed
OpenAlex ID: W4282983758
Cites:
Cited by:
Related to: 10